Related references
Note: Only part of the references are listed.Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors
M. Tanioka et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Survivin and escaping in therapy-induced cellular senescence
Qin Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma
Karl D. Lewis et al.
INVESTIGATIONAL NEW DRUGS (2011)
RADIATION-INDUCED SURVIVIN NUCLEAR ACCUMULATION IS LINKED TO DNA DAMAGE REPAIR
Gianni Capalbo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance
Yu Lei et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
CUL2 and STK11 as novel response-predictive genes for neoadjuvant radiochemotherapy in esophageal cancer
Ralf Metzger et al.
PHARMACOGENOMICS (2010)
Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study
Shahrokh F. Shariat et al.
CLINICAL CANCER RESEARCH (2009)
Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non-Small-Cell Lung Cancer
Giuseppe Giaccone et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Nuclear survivin expression predicts poorer prognosis in glioblastoma
Katsuyuki Shirai et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Identification of candidate genes involved in the radiosensitivity of esophageal cancer cells by microarray analysis
R. Ogawa et al.
DISEASES OF THE ESOPHAGUS (2008)
Significance of nuclear accumulation of Foxo3a in esophageal squamous cell carcinoma
Miao-Fen Chen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer
Daniel Vallbohmer et al.
PHARMACOGENOMICS (2008)
Opinion - Survivin, cancer networks and pathway-directed drug discovery
Dario C. Altieri
NATURE REVIEWS CANCER (2008)
Nuclear and cytoplasmic survivin: Molecular mechanism, prognostic, and therapeutic potential
Roland H. Stauber et al.
CANCER RESEARCH (2007)
High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy
Kolja Freier et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma
Antonio Rosato et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Tumor-specific gene expression using the survivin promoter is further increased by hypoxia
L Yang et al.
GENE THERAPY (2004)
Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation
K Fukuda et al.
BRITISH JOURNAL OF CANCER (2004)
Survivin, versatile modulation of cell division and apoptosis in cancer
DC Altieri
ONCOGENE (2003)
Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma
P Grabowski et al.
BRITISH JOURNAL OF CANCER (2003)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma
M Ikeguchi et al.
BRITISH JOURNAL OF CANCER (2002)
Share Paper
